A promising anti-inflammatory heart drug has failed a major trial, shaking a foundational theory of cardiovascular disease.
A promising anti-inflammatory heart drug has failed a major trial, shaking one of cardiology’s foundational assumptions
A promising anti-inflammatory heart drug has failed a major trial, shaking one of cardiology’s foundational assumptions.
OTHERS: 2026-08-13
Each individual neuron may be doing the work of a small neural network, not a simple switch. Neuroscientists have vastly underestimated brain cells’ computing power A new study finds that a single neu…
OTHERS: 2026-08-12
Europe’s fifth heat wave of 2026 is reshaping how the continent experiences summer — and what it costs. Europeans, Braced for 5th Heat Wave of 2026, Have Had Enough Temperatures reaching 43°C (109°F)…
A Novo Nordisk anti-inflammation drug failed a major trial, shaking one of cardiology’s foundational assumptions
A Novo Nordisk anti-inflammation drug failed a major trial, shaking one of cardiology’s foundational assumptions.
OTHERS: 2026-08-10
A landmark heart drug failure is forcing cardiologists to rethink whether inflammation actually causes cardiovascular disease. A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease —…
A major heart drug trial has failed, shaking the inflammation theory of cardiovascular disease
A major heart drug trial has failed, shaking the inflammation theory of cardiovascular disease.
A major anti-inflammation heart drug has failed its trial, upending a core theory of cardiovascular disease
A major anti-inflammation heart drug has failed its trial, upending a core theory of cardiovascular disease.
The FDA has approved Moderna’s mRNA flu vaccine, the first of its kind — and it outperforms the standard shot by up to 27 percent
The FDA has approved Moderna’s mRNA flu vaccine, the first of its kind — and it outperforms the standard shot by up to 27 percent.
OTHERS: 2026-08-06
The first mRNA flu vaccine just cleared the FDA — after the agency initially refused to even review it. F.D.A. Approves Moderna’s mRNA Flu Vaccine The reversal following public pressure is significant…